Medexprim

Embark on a Journey with ARTEMIs: A Revolution in Fatty Liver Disease Management! Today is #FattyLiverDay and this month is #FattyLiverMonth! Let's raise awareness and take action together! This year, we proudly launch #ARTEMIs, an EU-funded marvel destined to redefine the landscape of Metabolic dysfunction-associated fatty liver disease (#MASLD). Officially inaugurated on January 1st, ARTEMIs is a visionary initiative that aims to transform the approach to Europe's leading chronic liver disease, now surpassing viral hepatitis and alcohol-related causes. -🔬 What Sets ARTEMIs Apart? - Liver & Heart Virtual Twins: Advanced simulations to personalize patient care. Cutting-Edge Clinical Decision Support System (CDSS): Empowering clinicians with real-time insights. Interactive Visualization Tool Simplifying risk stratification and early diagnosis predictions for 7500 patients across 9 nations. 🌐 ARTEMIs Kick-Off Celebration! From the heart of Paris, a groundbreaking mission unfolds with 21 formidable partners, each contributing to a tapestry of innovation and hope. As we stand at this transformative crossroads, the ARTEMIs consortium embraces a shared ambition – to redefine the healthcare landscape for Fatty Liver Patients globally. Join us in this extraordinary endeavor to accelerate the translation of virtual twins into a personalized triumph over the complexities of MASLD! Together, we amplify our strength, proving that unity knows no borders. 🤝💪 🇪🇺 Meet Our Amazing Partners: EU Health and Food Safety WHO Regional Office for Europe Medexprim Cliniques universitaires Saint-Luc European Liver Patients' Association - ELPA Bournemouth University Imperial College London Greater Paris University Hospitals - AP-HP IHU ICAN (IIS La Fe) Hospital Universitari Vall d'Hebron | MATICAL INNOVATION Sheba Medical Center, Tel Hashomer, Sheba Medical Center, Tel Hashomer | Charité - Universitätsmedizin Berlin Heidelberg University The University of Freiburg Leipzig University DKFZ German Cancer Research Center Betthera | Medical University of Vienna Sapienza Università di Roma Join the Revolution! Follow Our Journey #ARTEMISHealthcareRevolution #TogetherStronger Stay Informed #Innovation #Data #ClinicalTrials #HorizonEurope #PersonalizedMedicine #RealWorldData Witness the dawn of a new era in healthcare! The ARTEMIs initiative is a groundbreaking effort to combat #FattyLiverDiseases by uniting clinicians, modelers, patients, and regulators to pioneer personalized medicine tools. With a regulatory-grade #MASLD cohort, Liver & Heart Virtual Twins, and a user-friendly smart dashboard, ARTEMIS is poised to lead the charge against Fatty Liver Diseases. 💪 Let's revolutionize healthcare together!** #HealthcareInnovation #MedicalResearch #PersonalizedMedicine EASL the home of Hepatology Vlad Ratziu Raluca Pais Irene Vignon-Clementel Cristina d'Almeida Mario Aznar

📣 Are you onboard #OHDSI June 1-3? 📣 We are attending the upcoming OHDSI (Observational Health Data Sciences & Informatics) Symposium! Aligned with OHDSI's mission, we are dedicated to advancing research by transforming #RealWorldData into actionable intelligence that drives better health outcomes. Don't miss our Data Scientist team, Mai Nguyen and Kalle Pärn, and explore our two posters to learn more about our efforts in "Advancing Value-Based Cancer Care" through the #ONCOVALUE project and "Enhancing Healthcare Insights" by empowering informed decision-making. 🔗 Discover BC Platforms' complete solution empowering your #DataManagement, #analytics, and insights: https://bit.ly/3VjIaLj ❓ Interested in learning more? Contact our experts: https://bit.ly/3VkKqSo #OHDSIEurope2024 #OMOP #EHDEN #RWD #HealthcareInnovation #Oncology #Research

🌟 Transforming Oncology with Real-World Data 🌟 Learn how BC Platforms helps revolutionize #CancerResearch and #CancerCare through the power of #RealWorldData (RWD). Discover how our globally sourced and analysis-ready oncology data can support your research to accelerate innovation and #DrugDevelopment. 🔗 Learn more here: https://bit.ly/45001dq ✨ Meet us in Chicago at #ASCO2024 to hear how our data can empower your organization's fight against #cancer: https://bit.ly/3yyDVTb #Oncology #RWD #RealWorldEvidence #EHR #NSCLC #lymphoma #leukemia #ASCO24 #PrecisionMedicine #pharma

🚀 Our team is heading to #ASCO24! 🚀 Join Mikaela Bruhammar ♦️, Kaj Työppönen, Weston Fox, and Alexandre Blanchot, Pharm.D at the forefront of oncology research. With a global oncology #RealWorldData footprint spanning North America, Europe, and Asia, we provide unparalleled insights and solutions. Schedule a meeting with our experts to discuss how our #RWD solutions and extensive experience in #oncology can support your innovation in #CancerResearch and #CancerCare. 👉 Schedule your meeting with us here: https://bit.ly/4atI87R We look forward to engaging in insightful discussions and forming valuable collaborations at ASCO! 🔬 Discover how our expertise in oncology can empower your organization's efforts in accelerating progress against #cancer. Download our #RWD Availability Snapshot: https://bit.ly/4bGEyZL #ASCO2024 #DrugDevelopment #RareDiseases #PrecisionMedicine #pharma

🔬 Yesterday was Clinical Trials Day, a time to honor the incredible efforts of clinical research professionals worldwide, organized by ACRP - Association of Clinical Research Professionals and supported by industry leaders like Sanofi and Merck. 🌎 At BC Platforms, we stand at the forefront of this journey with over two decades of experience in conducting clinical trials across Europe, the US, and Asia. Our commitment is rooted in a deep understanding of #RealWorldData, covering a wide spectrum of therapeutic areas such as #oncology, #neurology, rare diseases, and more. Navigating the complexities of regulatory requirements from #FDA, #EMEA, to #PMDA, we will provide unparalleled support at every stage of your clinical trial journey, with our unique blend of industry experience, service provider flexibility, and academic excellence. 🌟 To our valued research partners: thank you for your collaboration and tireless efforts! 🚀 Eager to propel your research forward? Explore how our scientific services can unlock your data potential: https://lnkd.in/e4mq8pjJ #ClinicalTrialsDay #ClinicalResearch #ClinicalTrials

Check out the latest article on CIAN Lung, a cohort that is changing the game in lung cancer research. #LungCancer is one of the deadliest cancers worldwide, driving the quest for better treatment outcomes. Introducing CIAN Lung by BC Platforms, a patient cohort initiative focusing on both non-small cell lung cancer ( #NSCLC ) and small cell lung cancer ( #SCLC ). This endeavor utilizes clinical and imaging datasets for qualitative and quantitative analyses, aiming to enhance predictive and diagnostic computational models. Read more: https://lnkd.in/dbSzrk-a #CIANLung #Cohort #LungCancerResearch #RealWorldData #MedicalInnovation

📣 Meet our panel of Leading Clinicians with just a few days left until our webinar! Join us on May 7th for a live discussion on the "Advances in #TargetedTreatment for Bladder Cancer", to dive into the importance of #RealWorldEvidence and its role in treatment decisions and personalized care for #BladderCancer patients. Register here https://lnkd.in/dzWgmH3Z to engage with our experts: 🔹 Dr Solomon Kamal-Uddin, Strategic Medical Director at BC Platforms: With a robust background in healthcare and clinical trials, Solomon brings a wealth of knowledge in pediatric and rare disease project management. He’s dedicated to merging clinical practice with educational excellence at the Medics Academy. 🔹 Dr Albert Carrión, Consultant Urologist at Hospital Universitari Vall d'Hebron: An expert in bladder cancer with significant experience in robotic surgery and molecular markers in #prostate cancer, Dr. Carrión is a panel member of the European Association of Urology. 🔹 Dr Manuel Castanheira Oliveira, Consultant Urologist at Centro Hospitalar Universitário de Santo António: A leader in urothelial #oncology, deeply involved in clinical and translational research, focusing on #biomarkers in bladder cancer. 🔹 Dr Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust: Specializing in thoracic and urologic tumors, Dr. Banna is a frontrunner in #immunotherapy and #PrecisionMedicine, with extensive experience in #ClinicalTrials and oncological education. 📅 Date: May 7, 2024  ⏰ Time: 3:00 PM - 4:00 PM CET 🎥 A recording will be available for all registrants Secure your spot today! #BladderCancerAwarenessDay #BladderCancerMonth24 #BladdersMatter #OncologyResearch #DrugDevelopment #RWD #treatment

✨ Join us on #BladderCancerAwarenessDay on May 7th at 15:00 CET for a 60-minute live webinar on the latest in #PrecisionTherapy for Bladder Cancer hosted by BC Platforms! 🔹 Gain insights into the heterogeneity of #BladderCancer, histology, and patient profiles, and their impact on #treatment strategies, 🔹 Learn how advances in #TargetedTherapies are shaping treatments for the Bladder Cancer population, 🔹 Understand obstacles in evidence generation and the role of #RealWorldData in shaping clinical guidelines, 🔹 Explore the use of #RWD in refining treatment approaches and decision-making, illustrated through a case study. 🔗 Secure your spot here: https://bit.ly/3Qh5bM5 #oncology #OncologyResearch #DrugDevelopment #BladdersMatter #BladderCancerMonth24

📅 Save the Date: 07 May 2024 | 15:00 CET Join us for a LIVE WEBINAR hosted by BC Platforms! 📣 Webinar Title: "New Horizons in Precision Therapy: How Recent Advances in Targeted Treatment Can Be Utilized in the Heterogenous Bladder Cancer Population" 👨⚕️ Host & Moderator: Dr. Solomon Kamal-Uddin of BC Platforms ✔️ Hear from the experts as they explore innovative #PrecisionTherapy strategies and their transformative potential for #BladderCancer treatment ✔️ Discover actionable insights into the future of #CancerCare ✔️ Stay at the forefront of the impact of recent #ClinicalTrials on developing and implementing new targeted treatment protocols. #PrecisionMedicine #BladderCancer #HealthcareInnovation #BladderCancerAwarenessMonth #BladderCancerAware

🌐BC Platforms and NTT Group's #partnership is set to transform healthcare in #Japan and beyond!🌟 Last week's opening ceremony for the Japan Precision Medicine Platform TM (JPP) launch in Tokyo, officially inaugurated the exclusive collaboration of BC Platforms and NTT Life Science Corporation. This marks a significant milestone in our joint mission to enhance patient outcomes through real-world data. Nino da Silva, Managing Director APAC at BC Platforms, says: "With NTT's innovative capabilities, we can offer global pharma companies access to real-world data, making it easier, faster, and more complete than any other alternative. We are delighted to be forming a combined, localized, team in Tokyo, in this unprecedented partnership with JPP, which will become a massive global medical data highway." Discover more: https://bit.ly/49BM0TR 📸 In the picture from left: Ken Matsuzak , VP, Head of Healthcare & Medical Business Planning Office, Nippon Telegraph and Telephone Corporation Hideki Tsukuda, SVP, Member of the Board, NTT Life Science Kouji Korekawa, President and CEO, NTT Life Science and President, PRiME-R Kaj Työppönen, CFO, BC Platforms Laurent Samama, Chairman of the Board, BC Platforms Akiko Kudo, SVP, Head of Alliance Department, Research and Development Market Strategy Division, Member of the Board, Nippon Telegraph and Telephone Corporation Nino da Silva, Managing Director APAC, BC Platforms Masaaki Tabata, VP of Life Innovation Department and Member of the Board, NTT Life Science #datadrivenhealthcare #healthcareinjapan #japanhealthcare #precisionmedicine #personalizedmedicine #collaboration #partnerships #realworldata #rwd #pharma #drugdevelopment #lifescience #datanetworks #healthcareresearch #healthcareinnovation #healthtech